Table 2.
Demographic data summary for all 635 PID patients.
| Parameters | All patients | CVID | Agammaglobulinemia | SCID | MHC class II deficiency |
|---|---|---|---|---|---|
| Number of patients | 635 | 320 | 250 | 54 | 11 |
| Gender (M/F) | 444/191 | 179/141 | 237/13 | 24/30 | 4/7 |
| Current age, mean; years (SD) | 12.7 (8.2) | 21.1 (15.7) | 18.0 (8.5) | 3.8 (4.9) | 7.9 (7.8) |
| Age at first OPV dose, mean; years (SD) | 0.6 (0.8) | 0.5 (1.6) | 0.4 (1.2) | 1.0 (2.6) | 0.6 (0.9) |
| Age at last dose, mean; years (SD) | 2.3 (2.0) | 4.3 (4.9) | 3.0 (3.6) | 2.2 (3.4) | NA |
| Exposure to OPV (Y/N) | 584/51 | 303/17 | 233/17 | 37/17 | 11/0 |
| Paralytic disease | 14 | 4 | 10 | 0 | 0 |
OPV, oral poliovirus vaccine; CVID, common variable immune deficiency; SCID, severe combined immunodeficiency; PID, primary immunodeficiency; MHC, major histocompatibility complex.